Oncology innovation continues to accelerate, but pharmaceutical manufacturers face mounting challenges, including rising cost pressures, intense competition, and increasingly crowded disease categories that make differentiation more difficult. As traditional commercialization models become less effective, organizations must adopt greater agility to succeed in a rapidly evolving market. This installment of EVERSANA’s oncology commercialization series focuses on the front lines of scientific exchange, where understanding changes in physician needs, clinical practice patterns, and market dynamics is essential. In an environment characterized by constant scientific advancement and uncertainty, companies need timely insights and responsive strategies to engage healthcare professionals effective

Join for free to read